Suppr超能文献

肺癌筛查实施过程中持续存在的挑战。

Ongoing challenges in implementation of lung cancer screening.

作者信息

Martini Katharina, Chassagnon Guillaume, Frauenfelder Thomas, Revel Marie-Pierre

机构信息

Radiology Department, Hôpital Cochin, APHP.Centre-Université de Paris, Paris, France.

Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland.

出版信息

Transl Lung Cancer Res. 2021 May;10(5):2347-2355. doi: 10.21037/tlcr-2021-1.

Abstract

Lung cancer is the leading cause of cancer deaths in Europe and around the world. Although available therapies have undergone considerable development in the past decades, the five-year survival rate for lung cancer remains low. This sobering outlook results mainly from the advanced stages of cancer most patients are diagnosed with. As the population at risk is relatively well defined and early stage disease is potentially curable, lung cancer outcomes may be improved by screening. Several studies already show that lung cancer screening (LCS) with low-dose computed tomography (LDCT) reduces lung cancer mortality. However, for a successful implementation of LCS programmes, several challenges have to be overcome: selection of high-risk individuals, standardization of nodule classification and measurement, specific training of radiologists, optimization of screening intervals and screening duration, handling of ancillary findings are some of the major points which should be addressed. Last but not least, the psychological impact of screening on screened individuals and the impact of potential false positive findings should not be neglected. The aim of this review is to discuss the different challenges of implementing LCS programmes and to give some hints on how to overcome them. Finally, we will also discuss the psychological impact of screening on quality of life and the importance of smoking cessation.

摘要

肺癌是欧洲乃至全球癌症死亡的主要原因。尽管在过去几十年中现有治疗方法有了长足发展,但肺癌的五年生存率仍然很低。这种严峻的前景主要是由于大多数患者确诊时癌症已处于晚期。由于高危人群相对明确,且早期疾病有可能治愈,通过筛查可能改善肺癌的治疗效果。多项研究已表明,低剂量计算机断层扫描(LDCT)肺癌筛查(LCS)可降低肺癌死亡率。然而,要成功实施LCS计划,必须克服几个挑战:高危个体的选择、结节分类和测量的标准化、放射科医生的专业培训、筛查间隔和筛查持续时间的优化、附属检查结果的处理等都是需要解决的要点。最后但同样重要的是,筛查对受检个体的心理影响以及潜在假阳性结果的影响不容忽视。本综述的目的是讨论实施LCS计划的不同挑战,并就如何克服这些挑战给出一些建议。最后,我们还将讨论筛查对生活质量的心理影响以及戒烟的重要性。

相似文献

1
Ongoing challenges in implementation of lung cancer screening.
Transl Lung Cancer Res. 2021 May;10(5):2347-2355. doi: 10.21037/tlcr-2021-1.
2
5
Lung cancer screening implementation: Complexities and priorities.
Respirology. 2020 Nov;25 Suppl 2:5-23. doi: 10.1111/resp.13963.
6
The Potential Role of Artificial Intelligence in Lung Cancer Screening Using Low-Dose Computed Tomography.
Diagnostics (Basel). 2022 Oct 8;12(10):2435. doi: 10.3390/diagnostics12102435.
8
Low-dose computed tomography screening reduces lung cancer mortality.
Adv Med Sci. 2018 Sep;63(2):230-236. doi: 10.1016/j.advms.2017.12.002. Epub 2018 Feb 6.
9
Real-world Clinical Implementation of Lung Cancer Screening-Evaluating Processes to Improve Screening Guidelines-Concordance.
J Gen Intern Med. 2020 Apr;35(4):1143-1152. doi: 10.1007/s11606-019-05539-w. Epub 2020 Jan 23.
10

引用本文的文献

1
Biomarker trajectory for earlier detection of lung cancer.
EBioMedicine. 2024 Oct;108:105377. doi: 10.1016/j.ebiom.2024.105377. Epub 2024 Sep 30.
2
Lung cancer screening: where do we stand?
Breathe (Sheff). 2024 Aug 27;20(2):230190. doi: 10.1183/20734735.0190-2023. eCollection 2024 Jun.
5
Potential of Inflammatory Protein Signatures for Enhanced Selection of People for Lung Cancer Screening.
Cancers (Basel). 2022 Apr 26;14(9):2146. doi: 10.3390/cancers14092146.

本文引用的文献

1
ESR/ERS statement paper on lung cancer screening.
Eur Radiol. 2020 Jun;30(6):3277-3294. doi: 10.1007/s00330-020-06727-7. Epub 2020 Feb 12.
2
Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial.
N Engl J Med. 2020 Feb 6;382(6):503-513. doi: 10.1056/NEJMoa1911793. Epub 2020 Jan 29.
3
Attending community-based lung cancer screening influences smoking behaviour in deprived populations.
Lung Cancer. 2020 Jan;139:41-46. doi: 10.1016/j.lungcan.2019.10.025. Epub 2019 Nov 1.
5
Optimal lung cancer screening intervals following a negative low-dose computed tomography result.
J Thorac Dis. 2019 Sep;11(Suppl 15):S1916-S1918. doi: 10.21037/jtd.2019.08.85.
8
Lung cancer mortality reduction by LDCT screening-Results from the randomized German LUSI trial.
Int J Cancer. 2020 Mar 15;146(6):1503-1513. doi: 10.1002/ijc.32486. Epub 2019 Jun 20.
9
End-to-end lung cancer screening with three-dimensional deep learning on low-dose chest computed tomography.
Nat Med. 2019 Jun;25(6):954-961. doi: 10.1038/s41591-019-0447-x. Epub 2019 May 20.
10
Cancer statistics, 2019.
CA Cancer J Clin. 2019 Jan;69(1):7-34. doi: 10.3322/caac.21551. Epub 2019 Jan 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验